2016 ICare4Autism International Autism Conference
The 2016 ICare4Autism International Autism Conference held on May 24th, 2016 at Montefiore Medical Center and Albert Einstein College of Medicine focused on Personalized Medicine and ASD. This program was designed to create a collaborative forum to enhance knowledge of biomedical research and global autism initiatives. With this knowledge, researchers, physicians, health care professionals, teachers, and parents can better care for and provide optimal services to people with ASD. The goal of the conference was for all attendees to increase their awareness of the current advances in diagnosis, research, and treatment of ASD and to provide information on resources they
may find valuable and might otherwise not have had access.
Dr. Joshua Weinstein, the CEO and Founder of ICare4Autism addressed the crowd of hundreds of people about this groundbreaking conference that will help create new opportunities and better the lives of children and adults with Autism. ICare4Autism was honored to have experts in the fields of science and medicine join them at this conference. He also spoke about the recent accomplishments of ICare4Autism globally such as the international initiatives and collaborations that took place with officials in Ghana, Singapore, Armenia and Nepal. Dr. Weinstein also spoke about ICare4Autism TV that will launch this summer bringing top news, research and success stories about autism to a worldwide audience.
Dr. Eric Hollander, the chairman of advisory committee for ICare4Autism and the Director of Autism and Obsessive-Compulsive Spectrum Program and Anxiety and Depression Program and Clinical Professor of Psychiatry and Behavioral Sciences, Montefiore Medical Center and Albert Einstein College of Medicine outlined ICare4Autism’s mission and goal of collaboration with like-minded organizations worldwide, as well as presented some of his scientific research, focusing on Novel and experimental therapeutics in autism spectrum disorder and prader willi syndromes.
Cuong Do, the Executive Vice President, Global Strategy Group at Samsung Founder and Chairman of Profectum Foundation, Identifor, Inc., Perceptivus, LLC, and Lysodel Therapeutics, Inc. spoke about app and web-based games designed to help individuals with autism and their families identify and strengthen abilities and motivations.
At the conclusion of this collaborative forum, participants were able to:
-
Assess the current understanding of autism spectrum and related disorders in research and practice.
-
Improve understanding of the current biomedical research and experimental therapeutics in Autism spectrum disorder, Prader willi, Fragile X, and Rett’s syndromes.
-
Apply standard practice guidelines for the assessment and treatment of people with ASD.
-
Integrate the current diagnostic measures and treatment options for autism spectrum disorder into private practice and/or research developments.
This activity was attended by researchers and practitioners in genetics, psychiatry, neurology, pediatrics, nursing, psychology, physicians, physician assistants, residents, fellows, medical students and other health care professionals, educators, social workers, individuals with ASD and members of their family.
​
See below the full list of speakers that presented at the conference:
Jonathan Kipnis, Ph.D.
Harrison Distinguished Teaching Professor of Neuroscience,
Director, Center for Brain Immunology and Glia (BIG), University of Virginia, Charlottesville, VA
“Neuro-immune interactions and the role for glia cells in brain function, development and diseases: Understanding basic mechanisms and development of therapeutic vaccines”
Cuong Do
Executive Vice President, Global Strategy Group at Samsung Founder,
Chairman of Profectum Foundation, Identifor, Inc., Perceptivus, LLC, and Lysodel Therapeutics, Inc.
“App and web-based game designed to help individuals with autism and their families identify and strengthen abilities and motivations”
Eric Hollander, M.D.
Director of Autism and Obsessive-Compulsive Spectrum Program and Anxiety and Depression Program, Clinical Professor of Psychiatry and Behavioral Science, Montefiore Medical Center and Albert Einstein College of Medicine, NY.
Chairman of the ICare4Autism advisory council.
“Novel and experimental therapeutics in autism spectrum disorder and Prader-Willi syndromes”
Judy Van de Water, Ph.D.
Professor, Department of Internal Medicine, UC Davis School of Medcine, CA,
Director, UC Davis Center for Children’s Enviornmental Health,
Deputy Director, UC Davis MIND Institute Intellectual and Developmental Disabilities Research Center,
The recipient of the Slifka-Ritvo IMFAR Innovative Basic Science research award for her contribution to autism research, and the McGovern Research Award for significant impact in the health field.
“Identifying a biomarker for autism in a subset of children: Maternal and antibody-related autism”
Hakon Hakonarson, M.D., Ph.D.
Director, Center for Applied Genomics at The Children’s Hospital of Philadelphia, Leonard Madlyn Abramson Resarch Center, PA.
Member of the ICare4Autism advisory council
“Gene networks underlying autism targeted for therapeutic intervention”
Inge – Marie Eigsti, Ph.D.
Associate Professor, Department of Psychological Sciences, University of Connecticut,
Research Affiliate, Haskins Laboratories, New Haven, CT
“Language Plasticity: Optimal outcomes and insights from autism”
Mady Hornig, M.A., M.D.
Director of Translational Research, Center for Infection and Immunity,
Associate Professor of Epidemiology, Mailman School of Public Health at Columbia University, USA
“Biologic Mechanisms in Autism”
Guest Faculty
W. Ted Brown, M.D., Ph.D.
Director, NYS Institute for Basic Research in ID/D, Scientific and Clinical Advisory Committee for the National Fragile X Foundation, NY
“The Fragile X Syndrome and Autism”
Aleksandra Djukic, M.D., Ph.D.
Professor of Clinical Neurology and Associate Professor of Clinical Pediatrics at AECM,
Director of the Tri-State Center for Rett Syndrome at Montefiore Medical Center, NYCommunication
“Deficits in Rett’s Syndrome”
Joshua Weinstein, Ph.D., M.B.A.
Founder & CEO of ICare4Autism
ICare4Autism Global Autism Initiatives & Closing Remarks
Joshua Weinstein, M.B.A., Ph.D. and Eric Hollander, M.D.